Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Sangamo and CHDI Foundation join to develop ZFP therapy for Huntington's disease

April 8, 2011

Celgene and ProMetic Life Sciences enter agreement for protein technologies

April 6, 2011

Aragen Bioscience receives NIAID subcontracts to develop mAbs for infectious diseases

April 6, 2011

MedImmune enters strategic collaboration with Inserm Transfert

April 6, 2011

OncoSec Medical and Inovio enter agreement for electroporation technology for cancer

April 6, 2011

Morphotek acquires tumor-targeting peptide platform from TransMolecular

April 5, 2011

Astellas licenses three agents to Cardeus Pharma

April 5, 2011

Algeta and Genzyme to collaborate on new approach to cancer treatment

April 4, 2011

Eisai and PRISM collaborate on inhibitors of complex between CREB-binding protein and catenin beta-1

April 4, 2011

Intercell and Novartis to advance Pseudomonas aeruginosa vaccine program

April 1, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.